[1] |
Pililis S, Lampsas S, Kountouri A, et al. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment[J]. Medicina(Kaunas), 2024, 60(10):1656. doi: 10.3390/medicina60101656.
|
[2] |
Stener-Victorin E, Teede H, Norman RJ, et al. Polycystic ovary syndrome[J]. Nat Rev Dis Primers, 2024, 10(1):27. doi: 10.1038/s41572-024-00511-3.
pmid: 38637590
|
[3] |
Luan YY, Zhang L, Peng YQ, et al. Immune regulation in polycystic ovary syndrome[J]. Clin Chim Acta, 2022, 531:265-272. doi: 10.1016/j.cca.2022.04.234.
|
[4] |
Ramzan H, Bukhari DA, Bibi Z, et al. Probiotic supplement for the treatment of polycystic ovarian syndrome[J]. Pharmacol Ther, 2025,266:108785. doi: 10.1016/j.pharmthera.2024.108785.
|
[5] |
高慧慧, 钱贝冉, 倪艳, 等. 多囊卵巢综合征发病机制研究进展[J]. 四川大学学报(医学版), 2024, 55(4):1049-1054. doi: 10.12182/20240760208.
|
[6] |
徐海鹏, 徐淑颖, 张淼, 等. 槲皮素对多囊卵巢综合征的治疗作用及机制研究[J]. 上海中医药杂志, 2025, 59(4):82-88,94. doi: 10.16305/j.1007-1334.2025.z20240511001.
|
[7] |
Shahid R, Iahtisham-Ul-Haq, Mahnoor, et al. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS)[J]. J Food Biochem, 2022, 46(7):e14117. doi: 10.1111/jfbc.14117.
|
[8] |
中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科学专家工作组, 中国医药教育协会代谢病专业委员会, 等. 减重代谢手术治疗肥胖症合并多囊卵巢综合征中国专家共识(2025年版)[J]. 中国普通外科杂志, 2025, 34(2):183-189. doi: 10.7659/j.issn.1005-6947.250057.
|
[9] |
石百超, 常惠, 王宇, 等. 肠道菌群在多囊卵巢综合征中的作用机制[J]. 国际生殖健康/计划生育杂志, 2024, 43(3):238-243. doi: 10.12280/gjszjk.20240078.
|
[10] |
Li P, Shuai P, Shen S, et al. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis[J]. BMC Med, 2023, 21(1):302. doi: 10.1186/s12916-023-02975-8.
pmid: 37559119
|
[11] |
Calcaterra V, Rossi V, Massini G, et al. Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity[J]. Nutrients, 2023, 15(14):3144. doi: 10.3390/nu15143144.
|
[12] |
贾凡, 郑冬雪, 陈如枫, 等. 不同造模时长对来曲唑诱导的多囊卵巢综合征大鼠肠道菌群的影响[J]. 海南医学院学报, 2022, 28(2):81-91. doi: 10.13210/j.cnki.jhmu.20210823.001.
|
[13] |
Lin W, Wen L, Wen J, et al. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome[J]. Front Endocrinol(Lausanne), 2021,12:747888. doi: 10.3389/fendo.2021.747888.
|
[14] |
Sun Y, Gao S, Ye C, et al. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications[J]. Front Cell Infect Microbiol, 2023,13:1142041. doi: 10.3389/fcimb.2023.1142041.
|
[15] |
Siddiqui R, Makhlouf Z, Alharbi AM, et al. The Gut Microbiome and Female Health[J]. Biology(Basel), 2022, 11(11):1683. doi: 10.3390/biology11111683.
|
[16] |
姚盼盼, 韩延华, 姜玥, 等. 肠道菌群对多囊卵巢综合征胰岛素抵抗的影响及治疗研究进展[J]. 辽宁中医药大学学报, 2025, 27(2):89-94. doi: 10.13194/j.issn.1673-842X.2025.02.016.
|
[17] |
Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis[J]. Eur J Nutr, 2020, 59(2):433-450. doi: 10.1007/s00394-019-02033-1.
pmid: 31256251
|
[18] |
Martinez Guevara D, Vidal Cañas S, Palacios I, et al. Effectiveness of Probiotics, Prebiotics, and Synbiotics in Managing Insulin Resistance and Hormonal Imbalance in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review of Randomized Clinical Trials[J]. Nutrients, 2024, 16(22):3916. doi: 10.3390/nu16223916.
|
[19] |
Calcaterra V, Verduci E, Cena H, et al. Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility[J]. Nutrients, 2021, 13(6):1848. doi: 10.3390/nu13061848.
|
[20] |
Salehi S, Allahverdy J, Pourjafar H, et al. Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy[J]. Probiotics Antimicrob Proteins, 2024, 16(5):1553-1565. doi: 10.1007/s12602-024-10223-5.
|
[21] |
Li G, Feng H, Mao XL, et al. The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials[J]. J Transl Med, 2023, 21(1):442. doi: 10.1186/s12967-023-04306-0.
pmid: 37415167
|
[22] |
Shoaei T, Heidari-Beni M, Tehrani HG, et al. Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial[J]. Int J Prev Med, 2015,6:27. doi: 10.4103/2008-7802.153866.
|
[23] |
徐双, 李妍. 褪黑素治疗多囊卵巢综合征的研究进展[J]. 现代妇产科进展, 2024, 33(12):941-943,947. doi: 10.13283/j.cnki.xdfckjz.2024.12.012.
|
[24] |
Kaur I, Suri V, Sachdeva N, et al. Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study[J]. Eur J Nutr, 2022, 61(8):4145-4154. doi: 10.1007/s00394-022-02959-z.
pmid: 35857132
|
[25] |
Zhang J, Sun Z, Jiang S, et al. Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis[J]. mSystems, 2019, 4(2):e00017-00019. doi: 10.1128/mSystems.00017-19.
|
[26] |
Guo Y, Qi Y, Yang X, et al. Association between Polycystic Ovary Syndrome and Gut Microbiota[J]. PLoS One, 2016, 11(4):e0153196. doi: 10.1371/journal.pone.0153196.
|
[27] |
Palomba S, Santagni S, Falbo A, et al. Complications and challenges associated with polycystic ovary syndrome: current perspectives[J]. Int J Womens Health, 2015, 7:745-763. doi: 10.2147/IJWH.S70314.
pmid: 26261426
|
[28] |
郝静茹, 窦真, 赵晓丽, 等. 多囊卵巢综合征脂质代谢异常对子宫内膜容受性影响的研究进展[J]. 实用妇科内分泌电子杂志, 2024, 11(3):35-37. doi: 10.3969/j.issn.2095-8803.2024.03.012.
|
[29] |
Cai WY, Luo X, Chen E, et al. Serum Lipid Levels and Treatment Outcomes in Women Undergoing Assisted Reproduction: A Retrospective Cohort Study[J]. Front Endocrinol(Lausanne), 2021,12:633766. doi: 10.3389/fendo.2021.633766.
|
[30] |
Hu X, Wang W, Su X, et al. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis[J]. PeerJ, 2023,11:e16410. doi: 10.7717/peerj.16410.
|
[31] |
Zarezadeh M, Musazadeh V, Faghfouri AH, et al. Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis[J]. Crit Rev Food Sci Nutr, 2023, 63(2):145-158. doi: 10.1080/10408398.2021.2004578.
|
[32] |
Karimi E, Heshmati J, Shirzad N, et al. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial[J]. Lipids Health Dis, 2020, 19(1):60. doi: 10.1186/s12944-020-01244-4.
pmid: 32248805
|
[33] |
Jamilian M, Mansury S, Bahmani F, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome[J]. J Ovarian Res, 2018, 11(1):80. doi: 10.1186/s13048-018-0457-1.
pmid: 30217229
|
[34] |
Menichini D, Ughetti C, Monari F, et al. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature[J]. Gynecol Endocrinol, 2022, 38(8):623-631. doi: 10.1080/09513590.2022.2089106.
|
[35] |
Ghanei N, Rezaei N, Amiri AG, et al. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial[J]. J Funct Foods, 2018, 42:306-311. doi: 10.1016/j.jff.2017.12.047.
|
[36] |
Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis[J]. Hum Reprod, 2017, 32(5):1075-1091. doi: 10.1093/humrep/dex044.
|
[37] |
许洋, 张浩琳, 王传社, 等. 情志因素影响多囊卵巢综合征发生发展的研究进展[J]. 中华中医药杂志, 2019, 34(9):4193-4196.
|
[38] |
Ostadmohammadi V, Jamilian M, Bahmani F, et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome[J]. J Ovarian Res, 2019, 12(1):5. doi: 10.1186/s13048-019-0480-x.
pmid: 30665436
|
[39] |
Ahire JJ, Rohilla A, Kumar V, et al. Quality Management of Probiotics: Ensuring Safety and Maximizing Health Benefits[J]. Curr Microbiol, 2023, 81(1):1. doi: 10.1007/s00284-023-03526-3.
pmid: 37935938
|